The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Precision Diagnosis and Therapy for Early Stage Lung Cancer
Official Title: Key Technology in Precision Diagnosis and Therapy for Early Stage Lung Cancer: a Single Arm Clinical Trial
Study ID: NCT02936804
Brief Summary: The present study is a single arm clinical trial aiming to improve the key technology in the diagnosis and treatment of early stage lung cancer. 60,000 high-risk subjects (age 45-70) are planned to recruit and assign to the Low Dose Computed Tomography (LDCT) screening arm (Baseline + 2 rounds of biennial repeated LDCT screening). Management of positive screening test will be carried out by a pre-specified protocol.
Detailed Description:
Minimum Age: 45 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Shanghai Chest hospital, Shanghai, Shanghai, China
Name: Baohui Han, MD, PhD
Affiliation: Shanghai Chest Hospital
Role: PRINCIPAL_INVESTIGATOR